-       Report 
   - October 2025
    -  186 Pages 
    Global
   
   From       €3186EUR$3,545USD£2,794GBP 
      €3540EUR$3,939USD£3,105GBP 
                -       Report 
   - April 2025
    -  200 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                -       Report 
   - November 2025
    -  375 Pages 
    Global
   
   From       €5258EUR$5,850USD£4,611GBP 
                -       Report 
   - January 2025
    -  140 Pages 
    Global
   
   From       €3550EUR$3,950USD£3,114GBP 
                -       Report 
   - June 2018
    -  315 Pages 
    Global
   
   From       €3145EUR$3,499USD£2,758GBP 
                 -       Report 
   - February 2023
    -  178 Pages 
    Global
   
   From       €5302EUR$5,899USD£4,650GBP 
                -       Report 
   - February 2024
    -  86 Pages 
    Global
   
   From       €4449EUR$4,950USD£3,902GBP 
                -       Report 
   - June 2022
    -  73 Pages 
    Global
   
   From       €1753EUR$1,950USD£1,537GBP 
                -       Report 
   - October 2024
    -  70 Pages 
    Europe
   
   From       €854EUR$950USD£749GBP 
                -       Report 
   - October 2024
    -  70 Pages 
    China
   
   From       €854EUR$950USD£749GBP 
                -       Report 
   - October 2024
    -  70 Pages 
    France
   
   From       €854EUR$950USD£749GBP 
                -       Report 
   - October 2024
    -  70 Pages 
    Germany
   
   From       €854EUR$950USD£749GBP 
                -       Report 
   - October 2024
    -  70 Pages 
    India
   
   From       €854EUR$950USD£749GBP 
                  -       Report 
   - January 2025
    -  132 Pages 
    Global
   
   From       €854EUR$950USD£749GBP 
                -       Report 
   - October 2024
    -  70 Pages 
    Global
   
   From       €854EUR$950USD£749GBP 
                -       Report 
   - October 2024
    -  70 Pages 
    North America
   
   From       €854EUR$950USD£749GBP 
                -       Report 
   - October 2024
    -  70 Pages 
    Asia Pacific
   
   From       €854EUR$950USD£749GBP 
                -       Report 
   - October 2024
    -  70 Pages 
    Latin America
   
   From       €854EUR$950USD£749GBP 
                -       Report 
   - October 2024
    -  70 Pages 
    Japan
   
   From       €854EUR$950USD£749GBP 
             
         Computer Aided Drug Discovery (CADD) is a technology-driven approach to drug discovery that uses computer-based methods to identify and develop new drugs. CADD combines the power of computational chemistry, bioinformatics, and machine learning to identify and optimize potential drug candidates. CADD can be used to identify novel drug targets, design and optimize drug molecules, and predict drug-target interactions. CADD can also be used to predict drug metabolism and toxicity, and to identify    potential drug-drug interactions.
CADD has become an important tool in the drug discovery process, allowing researchers to rapidly identify and develop new drugs. CADD can reduce the time and cost associated with drug discovery, and can help to identify novel drug targets and optimize drug molecules.
Some companies in the CADD market include Schrödinger, ChemAxon, Accelrys, and OpenEye Scientific Software. Show Less   Read more